These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 38771845)

  • 1. Autoimmune Rheumatic Diseases and Outcomes Following Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Ang SP; Chia JE; Misra K; Krittanawong C; Iglesias J; Gewirtz D; Mukherjee D
    Angiology; 2024 May; ():33197241255167. PubMed ID: 38771845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous coronary intervention outcomes in patients with rheumatoid arthritis, systemic lupus erythematosus and systemic sclerosis.
    Martinez SC; Mohamed M; Potts J; Abhishek A; Roddy E; Savage M; Bharadwaj A; Kwok CS; Bagur R; Mamas MA
    Rheumatology (Oxford); 2020 Sep; 59(9):2512-2522. PubMed ID: 31990337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased 30-day and 1-year mortality rates and lower coronary revascularisation rates following acute myocardial infarction in patients with autoimmune rheumatic disease.
    Van Doornum S; Bohensky M; Tacey MA; Brand CA; Sundararajan V; Wicks IP
    Arthritis Res Ther; 2015 Feb; 17(1):38. PubMed ID: 25879786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Myocardial Infarction in Autoimmune Rheumatologic Disease: A Nationwide Analysis of Clinical Outcomes and Predictors of Management Strategy.
    Mohamed MO; Roddy E; Ya'qoub L; Myint PK; Al Alasnag M; Alraies C; Clarson L; Helliwell T; Mallen C; Fischman D; Al Shaibi K; Abhishek A; Mamas MA
    Mayo Clin Proc; 2021 Feb; 96(2):388-399. PubMed ID: 33248709
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 susceptibility and clinical outcomes in autoimmune inflammatory rheumatic diseases (AIRDs): a systematic review and meta-analysis.
    Shin JI; Kim SE; Lee MH; Kim MS; Lee SW; Park S; Shin YH; Yang JW; Song JM; Moon SY; Kim SY; Park Y; Suh DI; Yang JM; Cho SH; Jin HY; Hong SH; Won HH; Kronbichler A; Koyanagi A; Jacob L; Hwang J; Tizaoui K; Lee KH; Kim JH; Yon DK; Smith L
    Eur Rev Med Pharmacol Sci; 2022 May; 26(10):3760-3770. PubMed ID: 35647859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of patients with chronic inflammatory diseases after percutaneous coronary intervention.
    Marcusohn E; Zukermann R; Kerner A; Roguin A; Kobo O
    Catheter Cardiovasc Interv; 2021 Nov; 98(5):E655-E660. PubMed ID: 34259378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Mortality Following SARS-CoV-2 Infection in Rural Versus Urban Dwellers With Autoimmune or Inflammatory Rheumatic Disease: A Retrospective Cohort Analysis From the National COVID Cohort Collaborative.
    Anzalone AJ; Jackson LE; Singh N; Danila MI; Reisher E; Patel RC; Singh JA;
    Arthritis Care Res (Hoboken); 2024 Aug; ():. PubMed ID: 39158165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CovAID: Identification of factors associated with severe COVID-19 in patients with inflammatory rheumatism or autoimmune diseases.
    Chevalier K; Genin M; Jean TP; Avouac J; Flipo RM; Georgin-Lavialle S; El Mahou S; Pertuiset E; Pham T; Servettaz A; Marotte H; Domont F; Chazerain P; Devaux M; Mekinian A; Sellam J; Fautrel B; Rouzaud D; Ebstein E; Costedoat-Chalumeau N; Richez C; Hachulla E; Mariette X; Seror R
    Front Med (Lausanne); 2023; 10():1152587. PubMed ID: 37035330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravascular ultrasound to guide percutaneous coronary interventions: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(12):1-97. PubMed ID: 23074482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoimmune Diseases May Increase Adverse Cardiovascular Events After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis.
    Ma G; Zhao H; Fei Y; Shen A; Chen H; Li H
    Heart Lung Circ; 2019 Oct; 28(10):1510-1524. PubMed ID: 30126788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of percutaneous coronary intervention in patients with rheumatoid arthritis and systemic lupus erythematosus: an 11-year nationwide cohort study.
    Lai CH; Lai WW; Chiou MJ; Lin WC; Yang YJ; Li CY; Tsai LM
    Ann Rheum Dis; 2016 Jul; 75(7):1350-6. PubMed ID: 26286017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is vaccination against COVID-19 associated with autoimmune rheumatic disease flare? A self-controlled case series analysis.
    Nakafero G; Grainge MJ; Card T; Mallen CD; Nguyen Van-Tam JS; Williams HC; Abhishek A
    Rheumatology (Oxford); 2023 Apr; 62(4):1445-1450. PubMed ID: 36048896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of post-percutaneous coronary intervention fractional flow reserve: a systematic review and meta-analysis.
    Andersen BK; Ding D; Mogensen LJH; Tu S; Holm NR; Westra J; Wijns W
    Eur Heart J Qual Care Clin Outcomes; 2023 Feb; 9(2):99-108. PubMed ID: 36026514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical characteristics of autoimmune rheumatic disease-related organizing pneumonia.
    Dong X; Zheng Y; Wang L; Chen WH; Zhang YG; Fu Q
    Clin Rheumatol; 2018 Apr; 37(4):1027-1035. PubMed ID: 28748510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short- and long-term cardiovascular outcomes in insulin-treated versus non-insulin-treated diabetes mellitus patients after percutaneous coronary intervention: A systematic review and meta-analysis.
    Hassan W; Saquib J; Khatri M; Kazmi SK; Kotak S; Hassan H; Ahmed J
    Indian Heart J; 2022; 74(1):13-21. PubMed ID: 34906538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COVID-19 infection and efficacy of vaccination in patients with rheumatic diseases during Omicron outbreak in South Korea: a prospective cohort study.
    Kim YK; Kim JY; Jung JI; Park JK; Lee EY; Lee EB; Park JW
    RMD Open; 2023 Nov; 9(4):. PubMed ID: 37973535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paxlovid use is associated with lower risk of cardiovascular diseases in COVID-19 patients with autoimmune rheumatic diseases: a retrospective cohort study.
    Wang W; Wang YH; Huang CH; Hsieh TH; Ibarburu GH; Wei JC
    BMC Med; 2024 Mar; 22(1):117. PubMed ID: 38481216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of percutaneous coronary intervention for chronic total occlusions in the elderly: A systematic review and meta-analysis.
    Cui C; Sheng Z
    Clin Cardiol; 2021 Jan; 44(1):27-35. PubMed ID: 33332739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of diabetes mellitus on all and successful percutaneous coronary intervention outcomes for chronic total occlusions: A systematic review and meta-analysis.
    Guan J; Li X; Gong S; Li L
    Heart Lung; 2022; 55():108-116. PubMed ID: 35533491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of COVID-19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: A systematic review and meta-analysis.
    Al-Haideri M; Mohammad TAM; Darvishzadehdeldari S; Karbasi Z; Alimohammadi M; Faramarzi F; Khorasani S; Rasouli A; Tahmasebi S; Darvishi M; Akhavan-Sigari R
    Int J Rheum Dis; 2023 Jul; 26(7):1227-1234. PubMed ID: 37309305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.